Faron Pharmaceuticals - Innovative medical solutions (Part 2)

[OsakasOssi]

@\"ValkoinenPeura

Do you mean there that they received 6 million shares in the share issue? Pentwater was both an anchor investor in the share issue with a 3 million euro pot and a subscription guarantor with a 3 million euro pot. Based on the anchor investment, they received 6 million shares from the issue, and based on the subscription guarantee, roughly another .2 million shares.

I had no idea about this. Where can such information be found? I have been under the impression that Pentwater was an anchor investor, but they did not participate in subscribing for the unsubscribed shares. So, according to my understanding, they were not involved in guaranteeing the share issue. But I might be wrong.

@\"ValkoinenPeura

It is unlikely that Pentwater has sold the issue shares in the meantime, but a SWAP was made out of them immediately after the share issue was completed, and for some reason, it went unflagged (liputus / disclosure of major shareholdings). Now, however, the shares are obviously being dumped, and there are still a few million left to sell for next week.

This is interesting—what do you mean by a SWAP being made of the shares? A Cash SWAP, which they had, is specifically one where they do not need to own the shares, but they get the financial benefits or drawbacks from them. In other words, for the shares in their possession to become a Cash SWAP for them, they have to sell the shares to whoever they want to make the SWAP with. Or have I misunderstood something?